Skip to content
Catalyst

rosuvastatinPapers

Papers about rosuvastatin

papers
651
26 years, by papers

Newest first

301 to 350 of 651

Every paper here, unless its row says otherwiseReturned by a PubMed search for rosuvastatin

  • Rosuvastatin may reduce the incidence of cardiovascular events in patients with acute coronary syndromes receiving percutaneous coronary intervention by suppressing miR-155/SHIP-1 signaling pathway.

    Cardiovascular therapeutics2014PMID 25319951

  • Lipid-lowering efficacy of rosuvastatin.

    The Cochrane database of systematic reviews2014PMID 25415541

  • Safety profile of subjects treated to very low low-density lipoprotein cholesterol levels (<30 mg/dl) with rosuvastatin 20 mg daily (from JUPITER).

    The American journal of cardiology2014PMID 25439449

  • Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study.

    American heart journal2014PMID 25440809

  • The effect of infrequent low-dose rosuvastatin on the lipid profile.

    The Canadian journal of cardiology2014PMID 25442436

  • Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).

    JACC. Cardiovascular interventions2014PMID 25523533

  • Differential metabolic effects of rosuvastatin and pravastatin in hypercholesterolemic patients.

    International journal of cardiology2013PMID 22204857

  • Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.

    Catheterization and cardiovascular interventions2013PMID 22517610

  • Effects of rosuvastatin with or without ezetimibe on clinical outcomes in patients undergoing elective vascular surgery: results of a pilot study.

    Journal of cardiovascular pharmacology and therapeutics2013PMID 22573476

  • Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.

    AIDS research and human retroviruses2013PMID 23098891

  • Effects of manidipine plus rosuvastatin versus olmesartan plus rosuvastatin on markers of insulin resistance in patients with impaired fasting glucose, hypertension, and mixed dyslipidemia.

    Journal of cardiovascular pharmacology and therapeutics2013PMID 23113965

  • Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucose.

    Metabolic syndrome and related disorders2013PMID 23170931

  • Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

    Circulation. Heart failure2013PMID 23230311

  • Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).

    The American journal of cardiology2013PMID 23237107

  • 25-hydroxyvitamin D insufficiency is associated with impaired renal endothelial function and both are improved with rosuvastatin treatment.

    Clinical research in cardiology2013PMID 23262496

  • Effect of rosuvastatin on cytokines after traumatic head injury.

    Journal of neurosurgery2013PMID 23289819

  • Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.

    Journal of cardiovascular pharmacology and therapeutics2013PMID 23364255

  • Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe.

    Lipids in health and disease2013PMID 23374898

  • Effect of rosuvastatin and sevelamer on the progression of coronary artery calcification in chronic kidney disease: a pilot study.

    Clinical nephrology2013PMID 23442255

  • Efficacy and plasma drug concentrations with nondaily dosing of rosuvastatin.

    The Canadian journal of cardiology2013PMID 23465343

  • ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics.

    Die Pharmazie2013PMID 23469685

  • Effect of long-term intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness--Justification for Atherosclerosis Regression Treatment (JART) extension study.

    Circulation journal2013PMID 23486191

  • Usefulness of rosuvastatin to prevent periprocedural myocardial injury in patients undergoing elective coronary intervention.

    The American journal of cardiology2013PMID 23507709

  • Comparison of switch to the highest dose of rosuvastatin vs. add-on nicotinic acid vs. add-on fenofibrate for mixed dyslipidaemia.

    International journal of clinical practice2013PMID 23510018

  • Effects of simvastatin and rosuvastatin on RAS protein, matrix metalloproteinases and NF-κB in lung cancer and in normal pulmonary tissues.

    Cell proliferation2013PMID 23510472

  • Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin.

    European journal of gastroenterology & hepatology2013PMID 23524525

  • Enhancement of human oral bioavailability and in vitro antitumor activity of rosuvastatin via spray dried self-nanoemulsifying drug delivery system.

    Journal of biomedical nanotechnology2013PMID 23627065

  • Achieving recommended low density lipoprotein cholesterol goals and the factors associated with target achievement of hypercholesterolemia patients with rosuvastatin in primary care.

    Current medical research and opinion2013PMID 23647398

  • Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy.

    American heart journal2013PMID 23708174

  • Pharmacokinetics of rosuvastatin/olmesartan fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjects.

    Clinical therapeutics2013PMID 23810276

  • A randomized, double-blind study of fenofibric acid plus rosuvastatin compared with rosuvastatin alone in stage 3 chronic kidney disease.

    Clinical therapeutics2013PMID 23891363

  • Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis--a prospective case-series study.

    Arthritis research & therapy2013PMID 24008003

  • Amelioration of cisplatin-induced nephrotoxicity by statins.

    Indian journal of pharmacology2013PMID 24014910Tests rosuvastatin

  • Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes.

    Lipids in health and disease2013PMID 24053480

  • Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).

    Journal of the American College of Cardiology2013PMID 24076283

  • Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.

    Journal of the American College of Cardiology2013PMID 24076297

  • Design and baseline data of a pediatric study with rosuvastatin in familial hypercholesterolemia.

    Journal of clinical lipidology2013PMID 24079281

  • Comparison of the effect of simvastatin versus simvastatin/ezetimibe versus rosuvastatin on markers of inflammation and oxidative stress in subjects with hypercholesterolemia.

    Atherosclerosis2013PMID 24125402

  • Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia.

    International journal of cardiology2013PMID 24239156

  • Effects of rosuvastatin vs. simvastatin/ezetimibe on arterial wall stiffness in patients with coronary artery disease.

    Internal medicine (Tokyo, Japan)2013PMID 24334573

  • Efficacy of rosuvastatin in achieving target HDL, LDL, triglycerides and total cholesterol levels in type 2 diabetes mellitus (T2DM) with newly diagnosed dyslipidaemia: an open label, nonrandomised, non-interventional and observational study in India.

    The Journal of the Association of Physicians of India2013PMID 24772729

  • Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared to rosuvastatin 10 mg in high-risk patients with and without type 2 diabetes mellitus inadequately controlled despite prior statin monotherapy.

    Cardiovascular therapeutics2012PMID 20626402

  • Rosuvastatin combined with ramipril significantly reduced atheroma volume by anti-inflammatory mechanism: comparative analysis with rosuvastatin alone by intravascular ultrasound.

    International journal of cardiology2012PMID 21295363

  • Effect of intensive lipid-lowering treatment compared to moderate lipid-lowering treatment with rosuvastatin on endothelial function in high risk patients.

    International journal of cardiology2012PMID 21349594

  • Steady-state pharmacokinetic interactions of darunavir/ritonavir with lipid-lowering agent rosuvastatin.

    Journal of clinical pharmacology2012PMID 21712498

  • Impact of 10 mg rosuvastatin daily or alternate-day on lipid profile and inflammatory markers.

    Clinica chimica acta; international journal of clinical chemistry2012PMID 21983163

  • Loss of the preconditioning effect of rosuvastatin during sustained therapy: a human in vivo study.

    American journal of physiology2012PMID 22003053

  • Rosuvastatin, proprotein convertase subtilisin/kexin type 9 concentrations, and LDL cholesterol response: the JUPITER trial.

    Clinical chemistry2012PMID 22065156

  • Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study.

    Circulation journal2012PMID 22094911

  • Efficacy and safety of coadministration of rosuvastatin, ezetimibe, and colestimide in heterozygous familial hypercholesterolemia.

    The American journal of cardiology2012PMID 22112743

The next 50 papers

← Previous 50